EarningsQ2 2021 Earnings Report

Relmada Therapeutics (4E2) Q2 2021 Earnings Report

0 Followers

DE:4E2 Q2 2021 EPS Results

Actual EPS-€1.39

Consensus EPS-€1.31

Beat/MissMissed by -€0.08

One Year Ago EPS-€0.65

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2021

Date08/10/2021

TimeAfter Close

Conference CallTuesday, August 10, 2021

DE:4E2 Upcoming Earnings

Relmada Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.13 / -	-0.267	―
Aug 06, 2026	2026 (Q2)	-0.18 / -0.10	-0.267	63.33% (+0.17)
May 12, 2026	2026 (Q1)	-0.18 / -0.20	-0.517	62.07% (+0.32)
Mar 19, 2026	2025 (Q4)	-0.13 / -0.24	-0.553	56.45% (+0.31)
Nov 13, 2025	2025 (Q3)	-0.38 / -0.27	-0.642	58.33% (+0.37)
Aug 07, 2025	2025 (Q2)	-0.41 / -0.27	-0.526	49.15% (+0.26)
May 12, 2025	2025 (Q1)	-0.43 / -0.52	-0.642	19.44% (+0.12)
Mar 27, 2025	2024 (Q4)	-0.60 / -0.55	-0.749	26.19% (+0.20)
Nov 07, 2024	2024 (Q3)	-0.60 / -0.64	-0.651	1.37% (<+0.01)
Aug 07, 2024	2024 (Q2)	-0.74 / -0.53	-0.749	29.76% (+0.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed